UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

                       SEPTEMBER 4, 2007 (AUGUST 30, 2007)
                DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)

                         COMPETITIVE TECHNOLOGIES, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                    DELAWARE
                                    --------
                 (STATE OR OTHER JURISDICTION OF INCORPORATION)

                           1-8696          36-2664428
                           ------          ----------
          (COMMISSION FILE NUMBER)     (IRS EMPLOYER IDENTIFICATION NO.)


           777 COMMERCE DRIVE, SUITE 100, FAIRFIELD, CONNECTICUT 06825
           -----------------------------------------------------------
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)(ZIP CODE)

                                 (203) 368-6044
                                 --------------
               REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:

                                       N/A
          (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions

[ ]   Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))












                                        1

ITEM  8.01  OTHER  EVENTS

On August 30, Competitive Technologies, Inc. issued the following press release:

                     COMPETITIVE TECHNOLOGIES FILES LAWSUIT
                 AGAINST BEN MARCOVITCH AND OTHER CO-DEFENDANTS

FAIRFIELD,  CT  - (AUGUST 31, 2007) - COMPETITIVE TECHNOLOGIES, INC. (AMEX: CTT)
announced  that  it  filed a Federal complaint today against former CTT Director
Ben  Marcovitch  and  other co-defendants. Mr. Marcovitch was removed from CTT's
Board  of  Directors on August 8, 2007 by unanimous vote of CTT's five Directors
for  violating  CTT's  Code of Conduct. At that time, CTT also withdrew from its
involvement  with  Agrofrut,  a  nutraceutical  firm  brought  to  CTT  by  Mr.
Marcovitch.  Others named in the suit are Betty Rios Valencia, President and CEO
of Agrofrut and former spouse of Mr. Marcovitch, John Derek Elwin, III, a former
CTT  employee,  and Agrofrut, E.U. The suit was filed in the U.S. District Court
for  the  District  of  Connecticut.  In  its lawsuit, CTT requests, among other
relief,  punitive  damages  and  attorneys'  fees.

"We  state  in  our complaint that these parties conspired to loot the company's
treasury,"  said  John  B.  Nano,  CTT's  Chairman,  President  and  CEO.  "Our
investigation  has  determined  that  these parties have been subject to similar
allegations  for  past  dealings.  We have analyzed these issues, presenting our
findings  in  our  Federal  complaint  that  contains  details  that  will allow
shareholders  to understand the gravity of the charges. It is the opinion of CTT
and the Board of Directors that this lawsuit is required to recover our $750,000
and  to  settle  outstanding  issues  regarding  the  named  parties. The recent
in-depth  due  diligence  and  subsequent  investigation  by Breen & Associates,
conducted  prior  to  Mr. Marcovitch's removal from the Board, disclosed several
issues of credibility and raised serious concerns regarding the defendants named
in  today's  lawsuit."

As  announced  on  August  15,  2007,  CTT  retained  Greenberg Traurig, LLP, an
international  law  firm,  to  recover  the funds from Agrofrut, and Juan Carlos
Esguerra  of the Bogota, Colombia-based law firm, Esguerra, Barrera, Arriaga, to
handle  CTT's  affairs  in  Colombia.  Also,  as  stated, Breen & Associates, an
independent  investigative  firm,  developed  evidence  that  showed  that  Mr.
Marcovitch  and  Agrofrut  provided  CTT's  Board  of  Directors  with false and
misleading information in a conspiracy to fraudulently loot CTT's treasury using
the  Agrofrut transaction. Included in those findings was the fact that Dr. Raul
Aragon  Davalos,  listed  as an executive of Agrofrut in papers submitted by Mr.
Marcovitch and Agrofrut at a March 28, 2007 CTT Board meeting, had actually been
killed  in  a drive-by shooting in Cali, Colombia on February 28, 2007. Dr. Raul
Aragon  Davalos's  assassination  was  known  to  Mr.  Marcovitch  and  Ms. Rios
Valencia,  as well as to other executives of Agrofrut, but was never revealed to
CTT  by them. Mr. Marcovitch had admitted to a CTT outside counsel, and to a CTT
shareholder,  that  he  had attended Dr. Raul Aragon Davalos's funeral. Further,
the  investigations have shown that Dr. Raul Aragon Davalos was a convicted drug
trafficker  and  that Ms. Rios Valencia also has a drug conviction record. Among
other  things,  the  involvement of Ben Marcovitch, Betty Rios Valencia and John
Derek  Elwin,  III  with  convicted  drug traffickers resulted in CTT's decisive
actions  against  these  individuals.

Mr.  Nano  added,  "We  expect  to  recover  the  majority of the funds from the
Agrofrut  transaction,  if not more. CTT continues to move ahead. We are further
developing  our  interest  in  the growing nutraceutical industry, including the
glycemic reduction nutraceutical and green tea polyphenol compounds currently in
our  portfolio.  We  are  also  aggressively  marketing  our  newly  acquired
technologies  for  pain management and stress reduction, and other technologies,
including  our HB LEDs, bone biomaterial, cholesterol trapping and regeneration,
and  Lupus  diagnostic  and  monitoring,  to  drive  revenue  growth,  improve
profitability  and  create  shareholder  value."


                                        2

ABOUT  COMPETITIVE  TECHNOLOGIES,  INC.

Competitive  Technologies,  established  in  1968,  is a full service technology
transfer and licensing provider focused on the technology needs of its customers
and transforming those requirements into commercially viable solutions. CTT is a
global  leader  in  identifying,  developing  and  commercializing  innovative
technologies  in  life,  electronic,  nano,  and  physical sciences developed by
universities,  companies  and inventors. CTT maximizes the value of intellectual
assets  for  the benefit of its customers, clients and shareholders. Visit CTT's
website:  www.competitivetech.net

Statements about our future expectations are "forward-looking statements" within
the  meaning  of  applicable  Federal Securities Laws, and are not guarantees of
future  performance.  When  used  herein,  the  words  "may,"  "will," "should,"
"anticipate,"  "believe,"  "appear,"  "intend,"  "plan,"  "expect,"  "estimate,"
"approximate,"  and  similar  expressions  are  intended  to  identify  such
forward-looking  statements.  These  statements  involve risks and uncertainties
inherent in our business, including those set forth in Item 1A under the caption
"Risk Factors," in our most recent Annual Report on Form 10-K for the year ended
July  31,  2006,  filed with the SEC on October 30, 2006, and other filings with
the  SEC, and are subject to change at any time. Our actual results could differ
materially  from these forward-looking statements. We undertake no obligation to
update  publicly  any  forward-looking  statement.

Direct inquiries to:     Johnnie D. Johnson, IR Services, LLC
                         Tel: 860 434 2465
                         E-mail: jdjohnson@corpirservices.com


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                         COMPETITIVE TECHNOLOGIES, INC.
                                  (Registrant)

Dated: September 4, 2007               By: /s/John B. Nano
                                       -------------------
                                       John B. Nano
                                       Chairman and Chief Executive Officer





















                                        3